Loading chat...
MI SCR0029
Concurrent Resolution
Status
9/28/2022
Primary Sponsor
Curtis VanderWall
Click for details
AI Summary
-
Urges the Governor of Michigan and specified executive departments to take action to make insulin more accessible and affordable for Michigan residents.
-
Cites that 12.3 percent of Michigan residents (over one million people) have diabetes, with 5 to 10 percent having type 1 diabetes requiring daily insulin to survive.
-
Notes that average insulin vial cost was $98.70 in 2018, resulting in monthly costs up to $300 for two to three vials, with injectable devices costing upwards of $700 for five pens.
-
Identifies that insulin retail prices increased 54 percent from 2014 to 2019, forcing many residents to skip or ration medication due to affordability concerns.
-
Directs state investigation into public and private partnerships to acquire insulin in bulk at lower prices or manufacture insulin, including development of a strategic plan for state production and distribution.
Legislative Description
A concurrent resolution to urge the Governor of Michigan, the Michigan Department of Health and Human Services, the Department of Insurance and Financial Services, the Department of Licensing and Regulatory Affairs, the Michigan Economic Development Corporation, and other executive departments to take action to make insulin more accessible and affordable.
Last Action
Referred To Committee On Health Policy And Human Services
9/28/2022